• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cannabinoids for the treatment of mental disorders.

作者信息

Crippa José Alexandre, de Lima Osório Flávia, Hallak Jaime, Guimarães Francisco Silveira, Zuardi Antonio Waldo

机构信息

Department of Neuroscience and Behavior, School of Medicine of Ribeirão Preto, University of São Paulo, Hospital das Clinicas Ribeirão Preto, São Paulo 14025600, Brazil; National Institute of Science and Technology for Translational Medicine, Brazilian National Council for Scientific and Technological Development, Brasília, Brazil.

Department of Neuroscience and Behavior, School of Medicine of Ribeirão Preto, University of São Paulo, Hospital das Clinicas Ribeirão Preto, São Paulo 14025600, Brazil; National Institute of Science and Technology for Translational Medicine, Brazilian National Council for Scientific and Technological Development, Brasília, Brazil.

出版信息

Lancet Psychiatry. 2020 Feb;7(2):125-126. doi: 10.1016/S2215-0366(19)30516-4.

DOI:10.1016/S2215-0366(19)30516-4
PMID:31981533
Abstract
摘要

相似文献

1
Cannabinoids for the treatment of mental disorders.用于治疗精神障碍的大麻素。
Lancet Psychiatry. 2020 Feb;7(2):125-126. doi: 10.1016/S2215-0366(19)30516-4.
2
Cannabinoids for the treatment of mental disorders.
Lancet Psychiatry. 2020 Feb;7(2):126-127. doi: 10.1016/S2215-0366(19)30523-1.
3
Cannabinoids for the treatment of mental disorders.用于治疗精神障碍的大麻素类药物。
Lancet Psychiatry. 2020 Feb;7(2):125. doi: 10.1016/S2215-0366(19)30509-7.
4
Cannabinoids for the treatment of mental disorders - Author's reply.用于治疗精神障碍的大麻素——作者回复
Lancet Psychiatry. 2020 Feb;7(2):127-128. doi: 10.1016/S2215-0366(19)30526-7.
5
Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase.大麻素与单胺神经递质及其对单胺氧化酶的影响。
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jul 2;38(1):68-77. doi: 10.1016/j.pnpbp.2011.12.010. Epub 2011 Dec 30.
6
[The endogenous cannabinoid system. Therapeutic implications for neurologic and psychiatric disorders].[内源性大麻素系统。对神经和精神疾病的治疗意义]
Nervenarzt. 2005 Sep;76(9):1062, 1065-6, 1068-72 passim. doi: 10.1007/s00115-005-1888-7.
7
Cannabis in psychiatric disorders: the cart before the horse?大麻与精神疾病：本末倒置？
Lancet Psychiatry. 2019 Dec;6(12):968-969. doi: 10.1016/S2215-0366(19)30375-X. Epub 2019 Oct 28.
8
Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances.使用大麻素对多发性硬化症进行对症治疗：最新进展
Expert Rev Neurother. 2007 Sep;7(9):1157-63. doi: 10.1586/14737175.7.9.1157.
9
The Importance of Drug and Sex Effects in Psychiatric Research.药物和性效应在精神病学研究中的重要性。
Biol Psychiatry. 2018 Nov 15;84(10):e71-e72. doi: 10.1016/j.biopsych.2018.08.011.
10
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.医用大麻素：系统评价和荟萃分析。
JAMA. 2015;313(24):2456-73. doi: 10.1001/jama.2015.6358.